Clinical Trial: Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps

Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL

Official Title: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Efficacy and Safety Study of SHR-1905 in Patiens With Chronic Rhinosinusitis With Nasal Polyps

Brief Summary: The study is being conducted to evaluate the efficacy, and safety of SHR-1905 injection in subjects with chronic rhinosinusitis with nasal polyps (CRSwNP), as well as to explore the reasonable dosage of SHR-1905 injection for CRSwNP.

Detailed Summary:
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Current Primary Outcome: Change from baseline in NPS at Week 24.

Original Primary Outcome: Change from baseline in NPS at Week 24.

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Guangdong Hengrui Pharmaceutical Co., Ltd

Dates:
Date Received: May 25, 2023
Date Started: 2023-06
Date Completion: {'date': '2023-06', 'type': 'ESTIMATED'}
Last Updated: 2023-06-04
Last Verified: 2023-05